Clinical Trials Directory

Trials / Completed

CompletedNCT01154855

Periodontal Disease and Circulatory Microbial Components

Circulatory Microbial Components and Immune Regulators of Patients With Periodontal Disease and Rheumatoid Arthritis

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Accepted

Summary

The goal of this project is to study the immune activity of certain proteins present in the blood of patients with severe periodontal disease. Periodontal disease (gum disease) is the major cause of tooth loss among adults. Moderate to severe periodontal disease is reported to affect 5-15% of American adults. It begins with an infection of the tissues surrounding the teeth, and leads to a worsening inflammatory response. This study will aid in clarifying the way in which gum disease might affect certain systemic diseases.

Detailed description

This project will have two specific goals: 1. Identify microorganism components in the serum of patients with severe periodontitis; and 2. Characterize the immune regulator activity of periodontitis serum. This proposed feasibility study will then aid in providing the support for an increased sample size and other design requirements for larger, more expanded human clinical trial testing.In this study, forty (40) subjects will be divided into 2 groups: 1) Healthy oral status group and 2) Severe periodontal disease. Patients will be clinically screened using standard periodontal measurements.

Conditions

Interventions

TypeNameDescription
PROCEDUREProphylaxis ; Gross debridement for diseased patients1 per patient at 2nd visit lasting approximately 1 hour.

Timeline

Start date
2010-01-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2010-07-01
Last updated
2015-12-14

Source: ClinicalTrials.gov record NCT01154855. Inclusion in this directory is not an endorsement.